People · Operator
Named in public records as an officer, director or promoter · active 2014–2014 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Immune Pharmaceuticals Inc | — | Pharmaceuticals | Series A | $11.7M | $363.0M | 2014 |
Daniel G. Kazado at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel G. Kazado on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rene G. Lerer | 1 | 1 |
| Ana G. Stancic | 1 | 1 |
| Daniel G. Teper | 1 | 1 |
| David G. Sidransky | 1 | 1 |
| Isaac G. Kobrin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.